FDA Inspection
Ionis Pharmaceuticals Inc.Ionis Pharmaceuticals Inc. – FDA Inspection, Sep 29, 2023
Record Details
This FDA Inspection record concerns Ionis Pharmaceuticals Inc., with an inspection on September 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · da06818c-0f2a-4964-be45-5000ce2d99e7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1221199
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Ionis Pharmaceuticals Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2026 | NAI | Drug Quality Assurance | |
| May 20, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 2, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 29, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ionis Pharmaceuticals Inc.
- FDA Inspection 1304626 - 2026-01-15
- FDA Inspection 1144090 - 2021-05-20
- FDA Inspection 1075511 - 2018-03-02
- FDA Inspection 953293 - 2015-10-29
- FDA Inspection 808370 - 2012-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.